2024/10/18 19:33:02 | |
---|---|
Price | |
0.3465 EUR | |
Difference | -10.00% (-0.04) |
ISIN | FR0013183985 |
Symbol | SIGHT |
Exchange | Berlin |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 37 EUR |
Benchmark | CAC 40 INDEX |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 0.384 EUR |
High | 0.398 EUR |
Low | 0.3465 EUR |
Close (prev. day) | 0.385 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 16 |
Last size | 0 |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/10/14 | Aktienempfehlungen Österreich | ||
2024/09/27 | Global Equity Ratings | ||
2024/09/27 | Aktienempfehlungen Global | ||
2024/09/23 | Aktienempfehlungen Österreich | ||
2024/09/13 | Equity Weekly |
2024/10/18 19:33:02 | |
---|---|
Price | |
0.3465 EUR | |
Difference | -10.00% (-0.04) |
ISIN | FR0013183985 |
Symbol | SIGHT |
Exchange | Berlin |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 37 EUR |
Benchmark | CAC 40 INDEX |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 0.384 EUR |
High | 0.398 EUR |
Low | 0.3465 EUR |
Close (prev. day) | 0.385 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 16 |
Last size | 0 |
6m | 1y | 3y | |
Perf (%) | -15.18% | -50.00% | -95.17% |
Perf (abs.) | -0.06 | -0.35 | -6.82 |
Beta | 1.12 | 1.05 | 1.00 |
Volatility | 68.01 | 80.18 | 116.60 |
Ø price 5 days | Ø volume 5 days (pcs.) | 0.3905 EUR (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 0.3762 EUR (0) |
Ø price 100 days | Ø volume 100 days (pcs.) | 0.3502 EUR (1) |
Ø price 250 days | Ø volume 250 days (pcs.) | 0.4034 EUR (0) |
YTD High | date | 0.5760 EUR (2024/03/06) |
YTD Low | date | 0.2800 EUR (2024/08/08) |
52 Weeks High | date | 0.6960 EUR (2023/10/19) |
52 Weeks Low | date | 0.2800 EUR (2024/08/08) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Tradegate | 2024/10/18 | 22:26 | 0.3465 EUR | 0.01 | 4 |
Stuttgart | 2024/10/18 | 15:47 | 0.3725 EUR | 0.00 | 10 |
Munich | 2024/10/18 | 08:05 | 0.3955 EUR | 0.00 | 2 |
London Stock Exchange | 2023/05/12 | 13:46 | 0.956 EUR | 0.01 | 1 |
Frankfurt | 2024/10/18 | 08:03 | 0.344 EUR | 0.00 | 2 |
FINRA other OTC Issues | 2024/07/22 | 18:57 | 0.32 USD | 0.00 | 1 |
Euronext Paris | 2024/10/18 | 17:35 | 0.3465 EUR | 0.30 | 440 |
Duesseldorf | 2024/10/18 | 08:11 | 0.3785 EUR | 0.00 | 3 |
Berlin | 2024/10/18 | 19:33 | 0.3465 EUR | 0.00 | 16 |
GENSIGHT BIOLOGICS SA |
- - |
rue du Faubourg Saint-Antoine 74 75012 Paris |
Telefon: +33 176217220 |
Fax: +33 176217221 |
E-mail: - |
- |
Michael Wyzga | Chairman of Supervisory Board |
José-Alain Sahel | Member of Supervisory Board |
Maritza McIntyre | Member of Supervisory Board |
Peter Goodfellow | Member of Supervisory Board |
Simone Seiter | Member of Supervisory Board |
Cédric Moreau | Member of Supervisory Board |
Elsy Boglioli Hofman | Member of Supervisory Board |
Françoise de Craecker | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).
The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.
Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.
The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.
By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.